News
A new combination vaccine could simplify protection against two major respiratory illnesses for older adults, according to a ...
For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
In most people with mild to moderate COVID, it can last 7–10 days. Symptomatic people can spread the infection to others from ...
Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...
1h
News-Medical.Net on MSNNasal vaccine boosters can trigger strong immune defenses in the respiratory tract, study findsMost vaccines — and boosters — are injected directly into muscle tissue, usually in the upper arm, to kickstart the body's immune system in the fight against disease.
Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...
The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...
If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...
Senior leaders at the US Food and Drug Administration began pushing Moderna Inc. and Pfizer Inc. to file for full, formal ...
Questions are answered by experts at the Oregon Health Authority, other state agencies or community partners. Questions and ...
The most commonly reported adverse events with the AZD1222 COVID-19 vaccine are headache and fatigue, a large-scale active ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results